Dopamine agonists in prolactinomas: when to withdraw?
Crossref DOI link: https://doi.org/10.1007/s11102-019-00989-1
Published Online: 2019-09-25
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Souteiro, Pedro http://orcid.org/0000-0002-1359-814X
Belo, Sandra
Carvalho, Davide
Text and Data Mining valid from 2019-09-25
Version of Record valid from 2019-09-25
Article History
First Online: 25 September 2019
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest.